28.12.2016 17:30:00

SmallCap Companies Trending in Various Sectors

NEW YORK, December 28, 2016 /PRNewswire/ --

http://www.Financialbuzz.com - Smallcaps are known to be high-risk high-reward companies. They are undoubtedly an attractive proposition for many who seek a cheap entrance into a company that has a long shot at achieving their business goals. To be a successful small-cap company certain requirements must be met. Public filings and disclosures are essential so investors have a fair chance to read between the lines. Keeping a strong operation, management and a progressive future for the company is required. In today's technology focused corporate world, a few sectors are particularly popular. Among them are renewable energy, cannabis, bio-techs, and new technologies. Vega Biofuels Inc. (OTC: VGPR), Easton Pharmaceuticals Inc. (OTC: EAPH), CGrowth Capital Inc. (OTC: CGRA), Signal Bay Inc. (OTC: SGBY), Aim Exploration Inc. (OTC: AEXE)

Renewable energy is a sector one of the sectors that is getting attention. Innovation, falling costs and major operation expansion in emerging economies are all factors that are expected to contribute for major growth. This sector includes wind energy, solar energy, hydro energy, as well as green energy sources like biofuels and lithium-ion batteries. According to a research published by the International Energy Agency, the share of renewable energy in global power generation is projected to increase to over 26% by 2020, from 22% in 2013. This means that by 2020 the amount of global electricity generation coming from renewable energy will be higher than today's combined electricity of China, India and Brazil. 

Vega Biofuels Inc. (OTC: VGPR) was formed to pursue the production and sale of biofuel products throughout the world. The Company markets two products, including a renewable energy product called Bio-coal and a soil enhancement called Biochar.

Vega Biofuels Inc. just announced this morning that the company, "provides the following update to its shareholders: 2016 has been a very productive year for the Company…In the first quarter, we responded to a Request for Proposal from a major US Utility to provide a quote for 8,000 tons of our Bio-Coal product.  From the list of companies providing quotes, Vega was chosen to move forward with the Utility.  During the second quarter of the year, we sent several samples of our Bio-Coal to the Utility for further testing to confirm that our product could perform safely and successfully in their coal-fired boiler.  

The Utility was impressed with our product and sent larger samples to the Western Research Institute to have testing done in an actual boiler that WRI has at their facility.  The results of this extensive testing proved that Vega's Bio-Coal out performed traditional coal in the boiler and could be burned in the Utility's plant as a clean-energy replacement for PRB coal. The extensive report by WRI is posted on our website vegabiofuels.com.

Subsequent to the WRI report being made public, we received requests from several other power companies that were interested in performing their own tests on our Bio-Coal.  As a result of the increase in the attention our Bio-Coal is receiving, we are projecting 2017 revenue will surpass two million dollars.  In order to accommodate the increased demand for our product, we completed construction in November on our generation four torrefaction machine.  The new design increases the production of each machine by approximately 25%.  

To protect the design of the Company's torrefaction machine, we secured the services of King & Spaulding, LLP to draft and submit a Provisional Patent with the U.S. Patent and Trademark Office under the title "Method and Apparatus for Torrefying Biomass".  The application disclosure relates generally to wood used as a fuel source, and more particularly to systems, methods, and devices for torrefying biomass, such as wood or other agricultural biomass.  We feel that our torrefaction machine is the most robust production unit currently in the marketplace.  

On behalf of our management team, we want to thank you for your continued support during our developmental stage.  We look forward to capitalizing on the increased interest in our Company as we move into 2017.  We will provide additional updates as we move forward."

Easton Pharmaceuticals Inc. (OTC: EAPH) and BMV Medica SA signed first sales & marketing agreement with multi-national pharmaceutical company, Gedeon Richter, for women's health, sales & marketing of its Gynofit, a lactic acid gel treatment of Bacterial Vaginosis. According to the statement, the sales and marketing agreement is for the country of Mexico, a pharmaceutical market representing almost 40% of Latin America, possessing double-digit annual growth rates. Marketing and Sales of "Gynofit" are expected to commence In February of 2017.

CGrowth Capital Inc. (OTC: CGRA) operates as a holding company for businesses and assets focusing on mining, minerals, and exploration activities in the US. The Company's services and solutions are designed to assist land owners with monetizing undervalued assets by bringing commodities, such as gold, silver, oil and gas, and dolomite to market. The Company will focus on acquiring land assets, while also providing partners and affiliates with management services, capital, contract management and logistical services necessary for the execution of operations.

Signal Bay Inc. (OTCQB: SGBY) with its subsidiaries, provides advisory, management, and analytical testing services to the legalized cannabis industry in the US. The Company's segments are Signal Bay Consulting (SBC) and CR Labs, Inc. (CRLB). SBC provides advisory, licensing and compliance services to the cannabis industry. SBC's clients are located in states that have state managed medical and/or recreational programs. SBC assists these companies with license applications, business planning, state compliance and ongoing operational support. CRLB provides analytical testing services to the cannabis industry. CRLB's clients are located in Oregon and consist of growers, processors and dispensaries. Signal Bay provides advisory and consulting services to cannabis companies, including license application support, regulatory compliance, market forecasts and operational insights. It also publishes industry information through online media, research reports and publications.

Aim Exploration Inc. (OTCQB: AEXE) operates as a mining company focusing on Anthracite production in Peru and global marketing through a joint venture corporation with Prina Energy. The Anthracite Coal concessions are controlled through their wholly owned subsidiary Aim Exploration in Peru and the company considers the mining concessions in Peru to be a high grade Anthracite Coal property in the Alto Chicama basin, in the province of Otuzco in Peru. Aim SA acquired these assets from Percana Mining Corp, a Peruvian corporation.

Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"

Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and PR marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site for advertising such companies. Financialbuzz.com has been compensated a total of nine thousand dollars for financial news dissemination and PR services by a third party non affiliate for vega biofuels inc. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on this site along with other financial news PR media services. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by

FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com

Url: FinancialBuzz.com

For further information:

Media Contact: info@financialbuzz.com , +1-877-601-1879


SOURCE FinancialBuzz.com

Nachrichten zu Easton Pharmaceuticals Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Easton Pharmaceuticals Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

CGrowth Capital Inc 0,00 73,68% CGrowth Capital Inc
Easton Pharmaceuticals Inc 0,00 0,00% Easton Pharmaceuticals Inc